MetaADEDB 2.0 @ LMMD
COMP protocol
(OMFHQUCUWSMFOJ-FMONCPFKSA-N)
Structure
SMILES
OC(=O)CC[C@@H](C(=O)O)NC(=O)c1ccc(cc1)N(Cc1cnc2c(n1)c(N)nc(n2)N)C.OCC(=O)[C@@]1(O)CC[C@@H]2[C@]1(C)CC(=O)[C@H]1[C@H]2CCC2=CC(=O)C=C[C@]12C.O=CN1c2c(OC)c(ccc2[C@]23[C@@H]1[C@@](O)(C(=O)OC)[C@H](OC(=O)C)[C@]1([C@@H]3N(CC2)CC=C1)CC)[C@]1(C[C@H]2CN(CCc3c1[nH]c1c3cccc1)C[C@](C2)(O)CC)C(=O)OC.ClCCN(P1(=O)NCCCO1)CCCl
Molecular Formula:
C94H119Cl2N14O22P
Molecular Weight:
1898.910
Log P:
9.8945
Hydrogen Bond Acceptor:
35
Hydrogen Bond Donor:
11
TPSA:
524.76
CAS Number(s):
N/A
Synonym(s)
1.
COMP protocol
2.
MCOP regimen
3.
MEVP protocol
External Link(s)
MeSHC037238
PubChem Compound56842161
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Lymphoma, Non-Hodgkin17654614CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.